MedNews

  • Drug Industry News
  • FDA News & Alerts
  • Health & Medical News
You are here: Home / Health & Medical News / Alzheimer's / Simvastatin Halves Alzheimer’s and Parkinson’s Risks

Simvastatin Halves Alzheimer’s and Parkinson’s Risks

July 27, 2007 By MedNews Leave a Comment

The statin, Simvastatin, has been found to cut the risk of developing Alzheimer’s and Parkinson’s disease by 50 percent.

Researchers at Boston University School of Medicine analyzed diagnostic, pharmaceutical, and demographic data of around 4.5 million people. This data was collected from various medical centers across the country.
To analyze the effects, researchers used three different models and examined the effects of the statins simvastatin, lovastatin, and atorvastatin on people.

They found a considerable decline in the occurrence of Alzheimer’s as well as Parkinson’s disease in people on simvastatin in each of the three models.
It is speculated that simvastatin is more beneficial as it possesses both high potency and the capability to enter the brain.

Source: Boston University 

Filed Under: Alzheimer's, Parkinson's Disease Tagged With: alzheimers, parkinsons, simvastatin



Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search



Tag Cloud

alcohol alzheimers asthma breast cancer cancer children cholesterol dementia depression Diabetes diet drug abuse exercise fda flu food genetics geriatrics h1n1 heart heart attack heart disease high blood pressure HIV/AIDS hormone therapy hypertension lungs menopause mrsa NIH obesity pain pediatrics pregnancy prostate cancer seniors sleep smoking statistics stroke sun swine flu teens USA women's health

Recent Comments

  • Mia Fritz on Health Benefits of Dark Chocolate
  • Shilpa on Why Too Much Iron Can Be Dangerous
  • Racheal on Teen Pregnancy May Be Reduced by Sex Education in Schools, Says Study
  • Don on Prilosec, Nexium and Prevacid Tied to Higher Risk of Pneumonia
  • Meso on Brain Changes in Elderly Can Affect Mobility and Balance
  • About Us
  • Contact

Copyright © 2023 Mednews · Log in